Talnetant

Talnetant
Clinical data

ATC code	none
Identifiers
IUPAC name 3-hydroxy-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide
CAS Number	174636-32-9^Y
PubChem CID	133090
IUPHAR/BPS	2124
ChemSpider	117450^N
UNII	CZ3T9T146K
ECHA InfoCard	100.236.526
Chemical and physical data
Formula	C₂₅H₂₂N₂O₂
Molar mass	382.454 g/mol
3D model (Jmol)	Interactive image
SMILES CCC(C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)O
InChI InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)^N Key:BIAVGWDGIJKWRM-UHFFFAOYSA-N^N
^NY (what is this?)

Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome however its use as a potential antipsychotic drug for the treatment of schizophrenia has been discontinued.